Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported):  March 2, 2020


America Great Health

(Exact name of registrant as specified in charter)



(State or other jurisdiction of incorporation)





(Commission File Number)


(IRS Employer Identification No.)




1609 W Valley Blvd., #338,

Alhambra, CA 91803



(Address of principal executive offices)


(Zip Code)


Registrant's telephone number, including area code:  (626) 576-1299



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Securities registered pursuant to Section 12(b) of the Act:


Title of each class

Trading Symbol(s)

Name of each exchange on which registered 





Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company     ☐


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On February 5th, 2020, Andy Weichu Sheng has resigned from his position as the Chief Operating Officer (“COO”) of America Great Health (the “Company”). 

Effective April 1st, 2020, David Liu, will be appointed as the Company’s COO in replacement of Mr. Sheng. Mr. Liu has been a General Partner of a healthcare private equity firm Avoda Capital in Shanghai China; he’s also a founder and CEO of a healthcare management consulting company Cherokee Rose Group. Prior to that, he served as General Manager and Vice President of McKesson-US in its Asia Pacific region for ten years. Mr. Liu also served as COO one of the biggest e-commercial platform YesAsia.com in the past. Mr. Liu holds two Bachelor Degrees of Operational Research and Industrial Engineering Science, as well as a MBA Degree from Cornell University.






Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed by the undersigned hereunto duly authorized.




Date: March 2, 2020                        

By:     /s/ Mike Wang                                

Name:    Mike Wang

Title:      President